APA (7th ed.) Citation

DM, R., DG, C., A, M., O, F., N, B., WC, D., . . . R, K. (2016). Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: New mechanistic insights for rapid acting antidepressants. Translational psychiatry, 6(9), e894. https://doi.org/10.1038/tp.2016.145

Chicago Style (17th ed.) Citation

DM, Rotroff, Corum DG, Motsinger-Reif A, Fiehn O, Bottrel N, Drevets WC, Singh J, Salvadore G, and Kaddurah-Daouk R. "Metabolomic Signatures of Drug Response Phenotypes for Ketamine and Esketamine in Subjects with Refractory Major Depressive Disorder: New Mechanistic Insights for Rapid Acting Antidepressants." Translational Psychiatry 6, no. 9 (2016): e894. https://doi.org/10.1038/tp.2016.145.

MLA (9th ed.) Citation

DM, Rotroff, et al. "Metabolomic Signatures of Drug Response Phenotypes for Ketamine and Esketamine in Subjects with Refractory Major Depressive Disorder: New Mechanistic Insights for Rapid Acting Antidepressants." Translational Psychiatry, vol. 6, no. 9, 2016, p. e894, https://doi.org/10.1038/tp.2016.145.